Lunai Bioworks Inc. LNAI
1.93
(0.01)
(0.52%)
as of 25 Sep
- Market cap
- $8.8M
- P/E
- 0.0×
Follow LNAI
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(321.81%) | (308.01%) | (366.44%) | (325.46%) | |
| (207.76%) | (203.39%) | (212.74%) | (201.09%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
641.66% | 692.65% | 644.58% | 825.67% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(3.82) | (2.56) | (1.97) | (1.69) | |
Free Cash Flow |
(7.87) | (7.21) | (5.79) | (5.29) | |
Capital Expenditures |
— | — | (0.07) | (0.03) | |
Piotroski F-Score |
— | — | — | 2.00 | |
| Other line items | |||||
Cash ROIC |
37.73% | 58.05% | 43.80% | 82.19% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.04 | 0.06 | 0.05 | 0.04 | |
Depreciation/Fixed assets |
463.79 | 13,646.76 | 9,246.65 | 9,460.75 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.82) | (2.56) | (1.95) | (1.68) | |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.01) | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates